Join Troutman Pepper Partner Brett Mason for a podcast series analyzing the intersection of artificial intelligence (AI), health care, and the law.

In this installment, Brett is joined by Partner Judy O'Grady and Associate Kyle Dolinsky to discuss the FDA's approach to regulating AI in health care. Topics include AI's current and potential applications in medical devices and drug development, the FDA's proactive stance on AI innovation, and evolving regulatory frameworks.